Background This study aimed at investigating antiepileptic drug (AED) prescription
preferences in patients with brain tumor-related epilepsy (BTRE) among the European …

Epilepsy is the most common comorbidity in patients with brain tumors. Study Aims: To
define characteristics of brain tumor-related epilepsy (BTRE) patients and identify patterns of …

Background and purpose We assessed the prevalence and magnitude of neuropsychiatric
adverse events (NPAE s) associated with antiepileptic drugs (AED s) among patients with …

Epilepsy is a common clinical problem in patients with brain tumours, strongly affecting
patientsȁ9 quality of life. Tumour-related seizures are often difficult to control, and the …

Background Seizure control doesn't represent the only challenging goal in patients with
brain tumor-related epilepsy. Side effects have often taken precedence for patients' quality of …

The mechanism of epilepsy in brain tumor patients is probably multifactorial, and its
incidence depends on tumor type and location. Refractory epilepsy is common in patients …

Seizures are common complications for patients with brain tumors. No clear evidence exists
regarding the use of antiepileptic agents for prophylactic use yet newer agents are being …

Patients with glioblastoma (GBM) often suffer from symptomatic epilepsy. Older antiepileptic
drugs (AEDs) which affect the enzyme system cytochrome P450 have been in extensive use …

In cancer, epilepsy can be the manifestation of a primary brain tumour, metastatic disease,
vascular or surgical complications, opportunistic infection or secondary to anti-tumour …

Background Comprehensive data on the efficacy and tolerability of antiepileptic drugs (AED)
treatment in glioma patients with epilepsy are currently lacking. In this systematic review, we …